AzTrials
AzTrials

OsteoarthritisCTM-RRNCT07069179

Feasibility of Choose to Move Replacement Ready

A study testing Choose to Move Replacement Ready in people with Osteoarthritis and Osteoarthritis (OA) of the Knee, run by University of British Columbia at 1 site in Canada.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Choose to Move (CTM) is a 3-month, choice-based health-promoting program for low active older adults being scaled-up across British Columbia (BC), Canada. Recently, the investigators adapted CTM for the >14000 people in BC who are on surgical waitlists for total knee replacement or total hip replacement (TKR/THR) for… Read more about this study

Who is it for?
Ages 50 years and older
What is being tested?
Choose to Move Replacement Ready
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteCanada
Study dates
14 Jul 2025to Mar 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Activity coach hired by the Active Aging Society (activity coaches must speak English to participate in the evaluation);
  • English-speaking older adults (aged >=50 years) who participate in CTM-RR will be invited to participate in the evaluation
  • Referral partner (People who work in a healthcare setting who refer patients into the program)

Who cannot join

  • non-English speaking activity coach
  • non-English speaking referral partner

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Christa Hoy, MSc contact

604-675-2581

christa.hoy@ubc.ca

Canada1 site, 1 recruiting
  • Active Aging Research Team, Robert H. N. Ho Research Centre

    Vancouver, British Columbia, V5Z 1M9

    Recruiting

Other trials in Canada

About this study

Official title: Choose to Move Replacement Ready: A Feasibility Trial of a Virtual Health-promoting Intervention for People Awaiting Total Hip or Knee Replacement Surgery

Choose to Move (CTM) is a 3-month, choice-based health-promoting program for low active older adults being scaled-up across British Columbia (BC), Canada. Recently, the investigators adapted CTM for the >14000 people in BC who are on surgical waitlists for total knee replacement or total hip replacement (TKR/THR) for osteoarthritis (OA). The primary goal of this observational study is to learn if the adapted program, Choose to Move Replacement Ready (CTM-RR), is feasible to deliver to people with hip and/or knee osteoarthritis who are on surgical waitlists for TKR/THR.

Participants who enrol in CTM-RR will answer online survey questions about the program and about their physical activity, mobility, pain, function, quality of life, willingness to undergo surgery, overall perception of their joint condition, psychosocial health, self-efficacy, social isolation, loneliness, and sedentary time. CTM-RR activity coaches will also answer online survey questions about the program. CTM-RR participants, activity coaches, and referral partners will also participate in interviews about the program.

Read the detailed description

Choose to Move (CTM) an effective 3-month, choice-based health-promoting program for low active older adults being scaled-up in phases across British Columbia (BC), Canada. Choose to Move Replacement Ready (CTM-RR) is an adapted version of the program tailored to support individuals with hip and/or knee osteoarthritis on surgical waitlists for TKR/THR, with the overall goal of enhancing key health outcomes. Trained activity coaches hired by the Active Aging Society will deliver CTM-RR to individuals on surgical waitlists for TKR/THR. The investigators will then evaluate implementation of CTM-RR, and the impact of CTM-RR on participants' physical and social health.

The primary objective of this trial is to:

  1. Assess implementation outcomes (participant recruitment, retention, dose delivered/received, fidelity) of the adapted CTM model against predetermined feasibility targets. The secondary objectives are to:
  2. Describe implementation determinants (acceptability, feasibility, appropriateness) and outcomes (reach, adaptations, perceived participant responsiveness, adoption) of the adapted CTM model.
  3. Evaluate the preliminary estimates of effectiveness of CTM-RR. Specifically, whether CTM-RR increases participants' pre-operative moderate-to-vigorous physical activity, light physical activity, mobility, psychosocial health, and self-efficacy to manage their condition; improves their perception of their joint condition, function, and quality of life; and decreases pain, social isolation, loneliness, and sedentary time
  4. Assess whether participant-level health benefits, if any, are maintained 3 months after participants complete the CTM-RR program.

In partnership with the Active Aging Society, the investigators aim to deliver 6 CTM-RR online programs over 9-months to approximately 60 participants total across BC. There is no cost to participate in the CTM-RR program, and individuals may participate in CTM-RR regardless of whether they choose to be evaluated as part of this trial.

The investigators will conduct a feasibility trial using a hybrid implementation-effectiveness type 2 trial design. Data will be collected at 0 (baseline), 3 (post-intervention), and 6 (long-term follow-up) months to assess implementation and impact of CTM-RR, and maintenance of any program-related benefits. The investigators will also collect physical activity logs from program participants (weekly, during program participation).

Being tested
Choose to Move Replacement Ready
Keywords
Osteoarthritis, Implementation science, Social isolation, Physical activity, Mobility, Loneliness, Pain, Joint replacement, Feasibility, Acceptability, Fidelity
Medical subject headings
Osteoarthritis, Osteoarthritis, Hip, Mobility Limitation, Social Isolation, Pain, Sedentary Behavior, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Choose to Move Replacement ReadyBehavioural

    As described under study arm description.

Study groups in NCT07069179
Study groupRoleWhat they receive
Choose to Move Replacement ReadyExperimentalCTM-RR is a 3-month program for individuals with hip and/or knee osteoarthritis on surgical waitlists for total hip or total knee replacement that includes three required components: 1) a 30-min one-on-one virtual consultation (via Zoom) where activity coaches support participants to set goals and develop a PA action plan; 2) 8 virtual group meetings (via Zoom, 90-min each) facilitated by activity coaches, with small groups of participants (10/program) who provide peer support. Each meeting includes: i) two, 15-min movement breaks where participants perform structured hip and knee exercises delivered by the coach and ii) education and discussion on relevant topics (e.g. goal setting, PA, what to expect from surgery); 3) Home-based hip and knee exercises to complete independently, 2x/week. Optional components of CTM-RR include 4) a bi-weekly newsletter distributed by the AAS and 5) peer support check-ins outside of group meetings.
Receives: Behavioral: Choose to Move Replacement Ready

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Implementation Outcome: Recruitment

    Obtained from program records. Proportion of people who attend the program information session, are eligible, and enrol in the program.

    Feasibility Target: Enrol 50% of people attending the program information session who are eligible to participate to the program.

    Measured: baseline

  2. Implementation Outcome: Retention

    Obtained from evaluation records. Proportion of participants who consent to the evaluation who complete each follow-up assessment.

    Feasibility target: A minimum of 80% of participants who consented to the evaluation (and are in the pre-operative period) completing each follow-up assessment.

    Measured: baseline, 3, 6 months

  3. Implementation Outcome: Dose delivered

    Obtained from post-program survey. Proportion of required intervention components (group meetings and one-on-one consultations) delivered by activity coaches.

    Feasibility target: Activity coaches delivering 90% of required intervention components (group meetings and one-on-one consultations).

    Measured: 3 months

  4. Implementation Outcome: Dose received

    Obtained from post-program survey. Proportion of participants who consent to the evaluation, attending required intervention components (group meetings and one-on-one consultation)

    Feasibility target: Participants who consent to the evaluation attending 6 out of 9 (>60%) of required intervention components (group meetings and one-on-one consultation)

    Measured: 3 months

  5. Implementation Outcome: Fidelity (Proportion of participants who adhered to prescribed exercise)

    Obtained from post-program survey. Measures adherence to prescribed frequency, intensity, duration, and type of exercises performed.

    80% of participants adhered to all of the following criteria:

    • on average, frequency= two sessions per week or greater
    • on average, intensity= 7 out of 10 rating of perceived exertion or greater
    • on average, duration= 20 minutes or greater
    • on average, exercises were completed as prescribed without omission or substitution of prescribed exercises

    Measured: 3 months

  6. Adverse events: Number of adverse events

    Obtained from post-program survey. Number of adverse events related to Choose to Move: Replacement Ready that required medical treatment and/or lasted two or more days.

    Measured: 3 months

Secondary outcomes (17)
  1. Change in physical activity

    Single-item physical activity questionnaire. Output measure is self-reported number of days engaging in ≥30 minutes of moderate-to-vigorous physical activity in the past week (range 0-7). Higher scores reflect a better outcome (i.e. increased physical activity)

    Measured: baseline, 3, 6 months

  2. Change in walking time

    International Physical Activity Questionnaire (IPAQ-SF): assesses self-reported weekly minutes of walking (minutes per week)

    Measured: baseline, 3, 6 months

  3. Change in sedentary time

    International Physical Activity Questionnaire (IPAQ-SF): assesses self-reported weekly minutes of sedentary time

    Measured: baseline, 3, 6 months

  4. Change in bone and muscle strengthening activity

    Single-item muscle strengthening activity survey. Number of days in past week doing activities that increase bone and muscle strength

    Measured: baseline, 3, 6 months

  5. Change in balance activity

    Single-item activity survey. Number of days in past week doing activities that improve balance.

    Measured: baseline, 3, 6 months

  6. Change in capacity for mobility

    Short-Form-36 health survey (SF-36) Physical Functioning Scale: two items assess self-reported ability to walk ¼ mile and 1 flight of stairs.

    Measured: baseline, 3, 6 months

  7. Change in social isolation

    Social Isolation Questionnaire: score (0-15) reflects the degree of social interaction and support. Higher scores indicate a greater level of social interaction and support.

    Measured: baseline, 3, 6 months

  8. Change in loneliness

    The 3-item U.S. Health and Retirement Study Participant Lifestyle Questionnaire reflects experiences of loneliness. Each item is scored on a scale of 1-3. The output variable is the summed score of the 3 items (range 3-9); Higher scores indicate greater perceived loneliness.

    Measured: baseline, 3, 6 months

  9. Change in ability to participate in daily activities

    The four-item PROMIS- Ability to Participate in Social Roles and Activities Scale- short form 4a will be used to assess perceived ability to perform one's usual social roles and activities. Each item is scored on a scale of 1-5. The output variable is the summed raw score of all 4-items (range 4-20) converted into a T-score (27.5-64.2) ; higher scores indicate greater ability to engage in social roles and activities.

    Measured: baseline, 3, 6 months

  10. Change in Hip disability and Osteoarthritis Outcome 12-item Score

    The 12-item Hip Disability and Osteoarthritis Outcome Score (HOOS-12) assesses patients' hip condition (pain, function, quality of life). Each item is scored on a scale of 0-10. The output variable is the average score of the 12-items (range 0-100); higher scores indicate worse hip problems.

    Measured: baseline, 3, 6 months

  11. Change in Knee disability and Osteoarthritis Outcome 12-item Score

    The 12-item Knee Disability and Osteoarthritis Outcome Score (KOOS-12) assesses patients' knee condition (pain, function, quality of life). Each item is scored on a scale of 0-10. The output variable is the average score of the 12-items (range 0-100); higher scores indicate worse knee problems.

    Measured: baseline, 3, 6 months

  12. Change in patient global assessment of target joint

    Single-item measure using a numerical rating scale: score (0-10) assesses the overall condition of the affected hip or knee joint. Higher scores indicate worse condition (severe symptoms).

    Measured: baseline, 3, 6 months

  13. Change in arthritis-specific self-efficacy

    The 8-item questionnaire assesses how certain an individual is that they can manage various aspects of their arthritis. Each item is scored on a scale of 1-10. The output variable is the average score of all 8-items (range 8-80); higher scores indicate more self-efficacy.

    Measured: baseline, 3, 6 months

  14. Change in pain intensity

    Pain Numerical Rating Scale (NRS): score (0-10) assesses pain intensity on average during the past week. Higher scores indicate worse pain intensity.

    Measured: baseline, 3, 6 months

  15. Change in willingness to undergo surgery

    One item will assess participants' willingness to undergo hip or knee replacement surgery. The question asks: "What is your current willingness to undergo a [total hip replacement surgery or total knee replacement surgery]?" The response options are: definitely unwilling, probably unwilling, unsure, probably willing or definitely willing. Definitely unwilling, probably unwilling, unsure= No, and probably willing or definitely willing=Yes. The output variable is self-reported willingness to undergo surgery (yes/no).

    Measured: baseline, 3, 6 months

  16. Change in anxiety

    The Generalized Anxiety Disorder 7-item scale (GAD-7) will be used to assess the presence of anxiety. Each item is scored on a scale of 0-3. The output variable is the summed total of all scores (range 0-21); higher scores indicate greater levels of anxiety.

    Measured: baseline, 3, 6 months

  17. Change in kinesiophobia

    The 11-item Tampa Scale for Kinesiophobia (TSK-11) assesses fear of movement in individuals with chronic pain. Each item is scored on a scale of 1-4. The output variable is the total summed score of all 11-items (range 11-44); higher scores indicate greater fear of movement.

    Measured: baseline, 3, 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jul 2025
  2. Study start14 Jul 2025
  3. Primary completionMar 2028 (estimated)
  4. Study completionMar 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07069179
Sponsor's protocol ID
H24-03805
Acronym
CTM-RR
Status last verified
Mar 2026
First submitted
7 Jul 2025
Last updated
12 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Peer MA, Lane J. The Knee Injury and Osteoarthritis Outcome Score (KOOS): a review of its psychometric properties in people undergoing total knee arthroplasty. J Orthop Sports Phys Ther. 2013 Jan;43(1):20-8. doi: 10.2519/jospt.2013.4057. Epub 2012 Dec 7.

    PubMed 23221356
  • Nilsdotter AK, Lohmander LS, Klassbo M, Roos EM. Hip disability and osteoarthritis outcome score (HOOS)--validity and responsiveness in total hip replacement. BMC Musculoskelet Disord. 2003 May 30;4:10. doi: 10.1186/1471-2474-4-10. Epub 2003 May 30.

    PubMed 12777182
  • Weiner BJ, Lewis CC, Stanick C, Powell BJ, Dorsey CN, Clary AS, Boynton MH, Halko H. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017 Aug 29;12(1):108. doi: 10.1186/s13012-017-0635-3.

    PubMed 28851459
  • Hawker GA, Bohm E, Dunbar MJ, Faris P, Jones CA, Noseworthy T, Ravi B, Woodhouse LJ, Marshall DA; BEST-Knee Study Team. Patient appropriateness for total knee arthroplasty and predicted probability of a good outcome. RMD Open. 2023 Apr;9(2):e002808. doi: 10.1136/rmdopen-2022-002808.

    PubMed 37068914
  • Alghadir AH, Anwer S, Iqbal A, Iqbal ZA. Test-retest reliability, validity, and minimum detectable change of visual analog, numerical rating, and verbal rating scales for measurement of osteoarthritic knee pain. J Pain Res. 2018 Apr 26;11:851-856. doi: 10.2147/JPR.S158847. eCollection 2018.

    PubMed 29731662
  • Jensen MP, Karoly P, Braver S. The measurement of clinical pain intensity: a comparison of six methods. Pain. 1986 Oct;27(1):117-126. doi: 10.1016/0304-3959(86)90228-9.

    PubMed 3785962
  • Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee Injury and Osteoarthritis Outcome Score (KOOS)--development of a self-administered outcome measure. J Orthop Sports Phys Ther. 1998 Aug;28(2):88-96. doi: 10.2519/jospt.1998.28.2.88.

    PubMed 9699158
  • Klassbo M, Larsson E, Mannevik E. Hip disability and osteoarthritis outcome score. An extension of the Western Ontario and McMaster Universities Osteoarthritis Index. Scand J Rheumatol. 2003;32(1):46-51. doi: 10.1080/03009740310000409.

    PubMed 12635946
  • Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002 Feb;52(2):69-77. doi: 10.1016/s0022-3999(01)00296-3.

    PubMed 11832252
  • Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1381-95. doi: 10.1249/01.MSS.0000078924.61453.FB.

    PubMed 12900694
  • Durlak JA, DuPre EP. Implementation matters: a review of research on the influence of implementation on program outcomes and the factors affecting implementation. Am J Community Psychol. 2008 Jun;41(3-4):327-50. doi: 10.1007/s10464-008-9165-0.

    PubMed 18322790
  • McKay H, Naylor PJ, Lau E, Gray SM, Wolfenden L, Milat A, Bauman A, Race D, Nettlefold L, Sims-Gould J. Implementation and scale-up of physical activity and behavioural nutrition interventions: an evaluation roadmap. Int J Behav Nutr Phys Act. 2019 Nov 7;16(1):102. doi: 10.1186/s12966-019-0868-4.

    PubMed 31699095
  • Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, Griffey R, Hensley M. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011 Mar;38(2):65-76. doi: 10.1007/s10488-010-0319-7.

    PubMed 20957426
  • Bauer GR, Braimoh J, Scheim AI, Dharma C. Transgender-inclusive measures of sex/gender for population surveys: Mixed-methods evaluation and recommendations. PLoS One. 2017 May 25;12(5):e0178043. doi: 10.1371/journal.pone.0178043. eCollection 2017.

    PubMed 28542498
  • Veroff JB. The dynamics of help-seeking in men and women: a national survey study. Psychiatry. 1981 Aug;44(3):189-200.

    PubMed 7267859

Questions about this trial

What is this clinical trial studying?

A study testing Choose to Move Replacement Ready in people with Osteoarthritis and Osteoarthritis (OA) of the Knee, run by University of British Columbia at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 12 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Douglas L Race, MSc (604-875-4111' ext. 21787, douglas.race@ubc.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Implementation Outcome: Recruitment (time frame: baseline). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07069179, which also lists 20 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in